Filing Details
- Accession Number:
- 0001415889-24-020484
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-31 21:05:11
- Reporting Period:
- 2024-07-29
- Accepted Time:
- 2024-07-31 21:05:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2010135 | John Fesko | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | President, Chief Bus. Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-07-29 | 929 | $102.77 | 108,462 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-07-31 | 100 | $5.40 | 108,562 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-07-31 | 100 | $0.00 | 100 | $5.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-12-09 | No | 4 | M | Direct |
Footnotes
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.
- The option shares are fully exercisable.
Billionaire Hedge Funds
